RxDoctor Payments DataLook up a doctor →

Jared Intaphan, MD

Pulmonary Disease · North Charleston, SCNPI 1639486160

Payments from drug & device makers

$14,958in general payments, 2019–2025

Across 637 payments — averaging $23.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • GSK$1K
  • Veran Medical Technologies, Inc.$1K
  • Boehringer Ingelheim$1K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Mallinckrodt Hospital Products Inc.$833
  • plus $7K from 41 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)115$2,335
GSK85$1,390
Veran Medical Technologies, Inc.5$1,383
Boehringer Ingelheim50$1,108
Regeneron Healthcare Solutions, Inc.31$1,013
Mallinckrodt Hospital Products Inc.29$833
Sanofi29$715
Takeda Pharmaceuticals U.S.A., Inc.30$663
United Therapeutics Corporation26$645
Mylan Specialty L.p.27$430
CSL Behring15$404
Insmed, Inc.14$390
Amgen26$337
Inari Medical, Inc.1$252
Grifols USA, LLC11$238
Actelion Pharmaceuticals US, Inc.14$230
Electromed, Inc.18$228
Genentech USA, Inc.11$215
Johnson & Johnson(2 entities)4$214
Vapotherm Inc7$199
Verona Pharma, Inc.9$187
ANI Pharmaceuticals, Inc.8$157
Pfizer8$154
Viatris Specialty LLC8$137
Novartis6$119
Astellas Pharma US Inc4$117
Gilead5$113
Harmony Biosciences LLC4$90
Philips North America LLC6$88
Merck4$73
Shire North American Group Inc3$49
Optinose US, Inc.3$47
Pharming Healthcare, Inc.2$42
Stryker1$41
Jazz Pharmaceuticals Inc.2$40
Catalyst Pharmaceuticals, Inc.2$34
Mallinckrodt Enterprises LLC2$34
Advanced Respiratory, Inc2$34
Circassia Inc.2$26
Shionogi Inc1$23
Sanofi-aventis U.S. LLC1$22
Inogen, Inc.1$20
Baxter Healthcare1$19
Resmed Corp1$18
Avadel CNS Pharmaceuticals, LLC1$17
Teva Pharmaceuticals USA, Inc.1$17
Scpharmaceuticals Inc.1$16

How this compares

$14,958 in reported general payments places this provider in the 75th percentile of 192 pulmonary disease providers in South Carolina.

See all pulmonary disease providers in South Carolina →

Medicare billing

Part B allowed, 2024
$186,202
Medicare patients
656
Services billed
2,068

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in North Charleston

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →